Guttman-McCabe Christopher bought ATEX

June 15, 2026 · Form 4 insider transaction

Guttman-McCabe Christopher bought 20,000 shares of Anterix Inc. at $37.42 per share, a transaction worth $748.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.